TEC
ELV icon

Tiger Eye Capital’s Elevance Health ELV Stock Holding History

Tiger Eye Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-9,383
Closed -$4.61M – 40
2022
Q1 		$4.61M Buy
+9,383
New +$4.29M 1.76% 12
2019
Q2 		– Sell
-46,719
Closed -$13.4M – 47
2019
Q1 		$13.4M Buy
46,719
+8,060
+21% +$2.33M 3.26% 15
2018
Q4 		$10.2M Sell
38,659
-25,489
-40% -$7.01M 4.29% 9
2018
Q3 		$17.6M Buy
64,148
+27,082
+73% +$7.03M 3.2% 15
2018
Q2 		$8.82M Sell
37,066
-9,971
-21% -$2.31M 1.78% 25
2018
Q1 		$10.3M Buy
47,037
+45,134
+2,372% +$10.6M 2.27% 20
2017
Q4 		$429K Buy
+1,903
New +$405K 0.07% 33

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Tiger Eye Capital's ELV Position: Q2 2022 in Review

Tiger Eye Capital sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 9,383 shares — an estimated $4.61M sold.

Tiger Eye Capital first reported a position in ELV in Q4 2017 and held it in 7 quarters. The position peaked at $17.6M in Q3 2018. 1,440 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Tiger Eye Capital reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • Tiger Eye Capital sold 9,383 Elevance Health shares in Q2 2022, an estimated $4.61M.
  • Tiger Eye Capital first reported a position in Elevance Health in Q4 2017 and held it in 7 quarters.
  • Tiger Eye Capital's Elevance Health position peaked at $17.6M in Q3 2018.
  • 1,440 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Tiger Eye Capital's 13F filing for Q2 2022, filed 15 Aug 2022.